Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Elamipretide for Sale > SS-31 High Quality Sema Weight Loss Petpide 99.0% High Purity MOST-C RETA tirz
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - large image1
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - image1
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - image2
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - image3
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - image4
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - image5
SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz buy - image6

SS-31 High Quality Sema Weight Loss Petpide 99.0% High Purity MOST-C RETA tirz

TDS 98 Inquiries

Unit Price: Get Latest Price
CAS No.:

736992-21-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shen Zhen

Brand:

QY

Packaging:

2mg 5mg 10mg 15mg 20mg 30mg per vial, 10 vials/boxes

Price valid (until):

2026-08-06

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,GHK-CU

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Name:Nina


    WhatsApp: +852 44859056


    Email: 1635596903@qq.com




    Model NO.
    ss31 Purity >99%
    Product Name Peptide Appearance White Powder
    Storage Cool Dry Area Sample Available
    MOQ 1box Packaging 10mg/Vial, 10 Vials/ Box
    Transport Package Carton Specification 2mg, 5mg, 10mg, 15mg, 20mg
    Trademark / Origin China

    Shop Tirzepatide TR5 TR30 TR70 TR120 High quality Provide COA Fitness and Weight Loss RETA SEMA  TIRZ-Detailed Image 1


       Semaglutide Detail  



    What is Semaglutide ?

        Semaglutide acts similar to a human glucagon peptide-1 (GLP-1) that works similar to a hormone produced in our body called incretin. Incretin stimulates insulin secretion and sugar metabolism in response to increased glucose levels which usually occurs after meals. Patients with type 2 diabetes are usually at a total loss with incretin production.


         Semaglutide is the newest GLP-1R agonist and was approved by the FDA for the treatment of T2DM in late 2017. The peptide is chemically similar to liraglutide, with the inclusion of two structural modifications (Lau, Bloch, et al., 2015). The first is the replacement of Gly with the non-proteinogenic amino acid 2-aminoisobutyric acid (Aib) at position 2. The second is the attachment of octadecanoic diacid to the side chain of Lys-26 through a short polyethylene glycol (PEG) spacer and a γ-glutamic acid linker. The amino acid substitution renders the peptide more resistant to DPP-4 compared to liraglutide, and the presence of the 18-carbon fatty acid moiety results in a high binding affinity for serum albumin, which translates to a half-life of approximately 7 days in humans.  It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing secretion, which leads to improved sugar metabolism. It is distributed as a metered in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action.



    •   Uses: Semaglutide is used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in overweight adults who may also have high blood pressure, diabetes, or high cholesterol. Semaglutide is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy. the stomach and may decrease appetite and cause weight loss.

    Is semaglutide worth it for weight loss?
    In these 68-week trials, semaglutide 2.4 mg was associated with significantly greater weight loss compared to placebo. Semaglutide differs from other GLP-1 receptor agonists by having a longer half-life and producing greater weight loss.

    How much weight can you lose in a week with semaglutide?
    Clinical trials have shown that study participants taking a weekly dose of semaglutide had an average reduction in body weight of 5-10 percent.




    Shop SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz-Detailed Image 2 Shop SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz-Detailed Image 3

    Shop SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz-Detailed Image 4 Shop SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz-Detailed Image 5 Shop SS-31 High Quality Sema Weight Loss Petpide  99.0% High Purity MOST-C RETA tirz-Detailed Image 6 Shop Tirzepatide TR5 TR30 TR70 TR120 High quality Provide COA Fitness and Weight Loss RETA SEMA  TIRZ-Detailed Image 5

    Shop Tirzepatide TR5 TR30 TR70 TR120 High quality Provide COA Fitness and Weight Loss RETA SEMA  TIRZ-Detailed Image 6

    •        


    Shop Tirzepatide TR5 TR30 TR70 TR120 High quality Provide COA Fitness and Weight Loss RETA SEMA  TIRZ-Detailed Image 7


     Payment


    Shop Tirzepatide TR5 TR30 TR70 TR120 High quality Provide COA Fitness and Weight Loss RETA SEMA  TIRZ-Detailed Image 8


      Shipping Method  


    Shop Tirzepatide TR5 TR30 TR70 TR120 High quality Provide COA Fitness and Weight Loss RETA SEMA  TIRZ-Detailed Image 9

    Why choose us?

    Professional, Rich Experience.

    1)Rich experience for Europe&North America&South America&Middle East&Asiaexport.

    2)Full experience of large numbers containers loading in Chinese sea port.

    How to proceed your order:

    Step 1:Please let me know the items you are favorable, quantities, and the destination country.

    Step 2:You confirm all detail, and offer purchasing order.

    Step 3:We send the detail price of our product and offer the suitable shipping method for reference.

    Step 4:You confirm the order and payment 100% in advance and send us the detailed contacting information, including contacting person/company,address,mobile number,ZIP code and your special requirements.

    Step5:We arrange the shipment according to your requirements, and tracking code will be offered once it is released, then you can track your parcel at any moment.

    Step 6:We offer after-sales services after service after you receive your parcel.

    ECHEMI Editorial Reference
    Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
    Elamipretide, also known as MTP 131, is a mitochondria-targeted peptide antioxidant. Elamipretide decreases inflammation and protect against a variety of neurological illnesses. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Elamipretide Synthetic is a single, non-glycosylated polypeptide chain containing 4 amino acids, having a molecular mass of 640 Dalton and a Molecular formula of C32H49N9O5 .

    Certificates

    Basic Info
    Product Name:

    Elamipretide

    Other Name:

    D-Arginyl-2,6-diMethyl-L-tyrosyl-L-lysyl-L-phenylalaninaMide;Elamipretide;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Elamipretide (TFA salt);SS-31;MTP-131;BENDAVIA;Bendavia);Elamipretide (SS-31;ELAMIPRETIDE, >99%

    CAS No.:

    736992-21-5

    Molecular Formula:

    C32H49N9O5

    InChIKeys:

    SFVLTCAESLKEHH-WKAQUBQDSA-N

    Molecular Weight:

    639.79

    Exact Mass:

    639.38566570

    EC Number:

    205-858-1

    UNII:

    87GWG91S09

    DSSTox ID:

    DTXSID50471988

    Color/Form:

    White to Off-White

    Characteristics
    Density:

    1.34±0.1 g/cm3(Predicted)

    PKA:

    10.10±0.25(Predicted)

    Research
    Class:

    Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)

    Status:

    FDA-approved (Forzinity) — Accelerated Approval 2025

    Mechanism:

    A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.

    Activity note:

    SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.

    Source:

    Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI

    Clinical Development:

    NCT03098797; NCT02814097; NCT02976038; NCT03354065

    FDA:

    Forzinity (approved 2025-09-19)

    References
    ChEMBL:

    CHEMBL3833370

    DrugBank:

    DB11981

    KEGG DRUG:

    D10925

    PubChem:

    PubChem

    Disclaimer:

    Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,GHK-CU

    Location:

    Plot 1, No. 205 Tongbao Road, Jiangdong Subdistrict, Yiwu City, Jinhua City, Zhejiang Province

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Year of Establishment:

    2026

  • Inquiry History
    98 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    SS-31 (Elamipretide MTP-131) CAS 736992-21-5 99% White Powder XO

    10  Oct 22, 2023
    Canada

    SS-31 (Elamipretide MTP-131) CAS 736992-21-5 99% White Powder XO

    1  Sep 28, 2023
    United States

    SS-31

    500 MG Feb 20, 2026
    Philippines

    Elamipretide

    100 MG Mar 17, 2026
    Philippines

    Elamipretide / SS-31

    5 G Mar 16, 2026
    Kazakstan

    SS-31

    500 MG May 22, 2026
    United States

    SS31

    10 MG Aug 28, 2026
    Australia

    SS-31

    30 MG Aug 24, 2026
    Brazil

    SS-31 Lyophilized Powder

    0.1 G Jul 9, 2026
    India

    Elamipretide

    1 G Jun 23, 2026
    France

    Elamipretide

    3 G Jun 19, 2026
    United States

    Elamipretide

    5 G Jun 18, 2026
    Netherlands

    ss31

    12 G Jun 8, 2026
    United States

    ss-31

    10 G May 19, 2026
    United States

    99% lypholized ss-31 Elamipretide 10mg and 20mg vials

    10 MT May 16, 2026
    United States

    Elamipretide

    200 MG Apr 27, 2026
    United States

    SS-31

    1 KG Apr 24, 2026
    United States

    ss-31

    500 MG Apr 13, 2026
    United States

    SS-31

    1 G Mar 23, 2026
    Canada

    Ss-31

    10 MT Mar 21, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.